Is a complete XENE research report available?

No complete published report is available for Xenon Pharmaceuticals Inc. (XENE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Xenon Pharmaceuticals Inc. (XENE)

NASDAQ: XENE · USD

$36.4

+0.37 (+1.0%)· Recorded snapshot

Market cap	3.5B
Net income (ttm)	-409.2M
EPS (ttm)	-$4.73
Shares out	96.8M
Volume	1,761,777
Beta	0.60

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -409.2M
EPS (ttm): -$4.73
Market cap: 3.5B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Metric	Value
Amount currency	USD
CIK code	0001582313
Company name	Xenon Pharmaceuticals Inc.
Country	Canada
Country code	US
CUSIP number	98420N105
Earnings date	2026-11-10
Earnings time	amc
Employees	370
Employees change	43
Employees growth	13.15%
Enterprise value	$2.3B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1996
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2014-11-05
Is primary listing	Yes
Is SPAC	No
ISIN number	CA98420N1050
Last 10-K release date	2026-02-26
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$3.5B
Market cap category	Mid-Cap
Next earnings date	2026-11-10
Options	Yes
Price	$36.38
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	XENE
Website	https://www.xenon-pharma.com

Metric

Value

Amount currency

USD

CIK code

0001582313

Company name

Xenon Pharmaceuticals Inc.

Country

Canada

Country code

CUSIP number

98420N105

Earnings date

2026-11-10

Earnings time

amc

Employees

370

Employees change

Employees growth

13.15%

Enterprise value

$2.3B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1996

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2014-11-05

Is primary listing

Yes

Is SPAC

ISIN number

CA98420N1050

Last 10-K release date

2026-02-26

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$3.5B

Market cap category

Mid-Cap

Next earnings date

2026-11-10

Options

Yes

Price

$36.38

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

XENE

Website

https://www.xenon-pharma.com

Metric	Value
Earnings yield	-12.99%
FCF / EV yield	-14.97%
FCF yield	-9.67%
Forward EV/Sales	2,688.85x
Forward P/S	4,161.84x
P/B ratio	2.8x
Price / tangible book value	2.82x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-12.99%

FCF / EV yield

-14.97%

FCF yield

-9.67%

Forward EV/Sales

2,688.85x

Forward P/S

4,161.84x

P/B ratio

2.8x

Price / tangible book value

2.82x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Profit per employee	$-1.1M
ROA	-28.02%
ROA (5Y)	-18.62%
ROCE	-35.31%
ROE	-43.62%
ROE (5Y)	-28.66%
ROIC	-29.18%

Metric

Value

Profit per employee

$-1.1M

ROA

-28.02%

ROA (5Y)

-18.62%

ROCE

-35.31%

ROE

-43.62%

ROE (5Y)

-28.66%

ROIC

-29.18%

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-1M
Depreciation and amortization	$2.4M
EBIT	$-441.6M
EBITDA	$-439.2M
EPS	$-4.73
FCF per share	$-3.50
Financing cash flow	$958.9M
Free cash flow	$-338.5M
Free cash flow minus SBC	$-400M
Gross profit	$-352.5M
Income taxes	$-1.9M
Investing cash flow	$-637.3M
Net cash flow	$-15.9M
Net income	$-409.2M
Operating cash flow minus SBC	$-399M
Operating income	$-441.6M
Stock-based compensation	$61.4M

Metric

Value

Capital expenditures

$-1M

Depreciation and amortization

$2.4M

EBIT

$-441.6M

EBITDA

$-439.2M

EPS

$-4.73

FCF per share

$-3.50

Financing cash flow

$958.9M

Free cash flow

$-338.5M

Free cash flow minus SBC

$-400M

Gross profit

$-352.5M

Income taxes

$-1.9M

Investing cash flow

$-637.3M

Net cash flow

$-15.9M

Net income

$-409.2M

Operating cash flow minus SBC

$-399M

Operating income

$-441.6M

Stock-based compensation

$61.4M

Metric	Value
Altman Z-Score	40.57
Book value per share	$12.84
Debt / equity	0.01
Long-term assets	$349.9M
Long-term liabilities	$8.4M
Net cash (debt)	$1.2B
Net cash / market cap	35.39%
Net cash growth	101.04%
Net debt / equity	-1
Piotroski F-Score	2
Property, plant and equipment	$13.2M
Shareholders' equity	$1.2B
Tangible book value	$1.2B
Tangible book value per share	$12.84
Total assets	$1.3B
Total cash	$930.7M
Total debt	$6.4M
Total liabilities	$53.4M
WACC	7.56%

Metric

Value

Altman Z-Score

40.57

Book value per share

$12.84

Debt / equity

0.01

Long-term assets

$349.9M

Long-term liabilities

$8.4M

Net cash (debt)

$1.2B

Net cash / market cap

35.39%

Net cash growth

101.04%

Net debt / equity

-1

Piotroski F-Score

Property, plant and equipment

$13.2M

Shareholders' equity

$1.2B

Tangible book value

$1.2B

Tangible book value per share

$12.84

Total assets

$1.3B

Total cash

$930.7M

Total debt

$6.4M

Total liabilities

$53.4M

WACC

7.56%

Metric	Value
Current assets	$945.9M
Current liabilities	$45M
Current ratio	21.02
Net working capital	$-28.5M
Quick ratio	20.71
Working capital	$900.9M

Metric

Value

Current assets

$945.9M

Current liabilities

$45M

Current ratio

21.02

Net working capital

$-28.5M

Quick ratio

20.71

Working capital

$900.9M

Metric	Value
Buyback yield / dilution	-10.31%
Dividend yield	0%
Shareholder yield	-10.31%

Metric

Value

Buyback yield / dilution

-10.31%

Dividend yield

Shareholder yield

-10.31%

Metric	Value
10Y price change	336.89%
10Y return CAGR	15.89%
10Y total return	336.89%
150-day SMA	$54.58
1D price change	1.03%
1M price change	-1.25%
1M total return	-1.25%
1W price change	0.58%
1W total return	0.58%
1Y price change	-12.91%
1Y return CAGR	-12.92%
1Y total return	-12.91%
20-day SMA	$35.97
200-day SMA	$52.40
3M price change	-44.54%
3M total return	-44.54%
3Y price change	18.17%
3Y return CAGR	5.72%
3Y total return	18.17%
50-day SMA	$46.29
50-day SMA vs 200-day SMA	50under200
52-week high	$72.66
52-week high date	2026-07-09
52-week low	$33.38
52-week low date	2026-10-16
5Y price change	21.24%
5Y return CAGR	3.93%
5Y total return	21.24%
6M price change	-32.77%
6M total return	-32.77%
All-time high	$72.66
All-time high date	2026-07-09
All-time low	$2.10
All-time low date	2017-11-16
Average true range (ATR)	$1.50
Average volume	1.5M
Beta (1Y)	0.39
Beta (2Y)	0.76
Beta (5Y)	0.6
Change from 52-week high	-49.93%
Change from 52-week low	8.99%
Change from all-time high	-49.79%
Change from all-time low	1,637.14%
Change from open	1.73%
Day's gap	-0.69%
Dollar volume	$64.1M
High price	$36.61
Low price	$35.56
Monthly RSI	43.06
Open price	$35.76
Position in 52-week range	78.1%
Premarket change	-0.36%
Premarket close	$36.01
Premarket price	$35.88
Premarket volume	2K
Previous close	$36.01
Price vs 150-day SMA	-33.17%
Price vs 20-day SMA	1.41%
Price vs 200-day SMA	-30.38%
Price vs 50-day SMA	-21.2%
Relative volume	1.15
RSI	39.54
Sharpe ratio	0.05
Sharpe ratio (3Y)	0.24
Sharpe ratio (5Y)	0.24
Sortino ratio	0.19
Sortino ratio (3Y)	0.52
Sortino ratio (5Y)	0.49
Volume	1.8M
Weekly RSI	32.91
YTD price change	-18.61%
YTD total return	-18.61%

Metric

Value

10Y price change

336.89%

10Y return CAGR

15.89%

10Y total return

336.89%

150-day SMA

$54.58

1D price change

1.03%

1M price change

-1.25%

1M total return

-1.25%

1W price change

0.58%

1W total return

0.58%

1Y price change

-12.91%

1Y return CAGR

-12.92%

1Y total return

-12.91%

20-day SMA

$35.97

200-day SMA

$52.40

3M price change

-44.54%

3M total return

-44.54%

3Y price change

18.17%

3Y return CAGR

5.72%

3Y total return

18.17%

50-day SMA

$46.29

50-day SMA vs 200-day SMA

50under200

52-week high

$72.66

52-week high date

2026-07-09

52-week low

$33.38

52-week low date

2026-10-16

5Y price change

21.24%

5Y return CAGR

3.93%

5Y total return

21.24%

6M price change

-32.77%

6M total return

-32.77%

All-time high

$72.66

All-time high date

2026-07-09

All-time low

$2.10

All-time low date

2017-11-16

Average true range (ATR)

$1.50

Average volume

1.5M

Beta (1Y)

0.39

Beta (2Y)

0.76

Beta (5Y)

0.6

Change from 52-week high

-49.93%

Change from 52-week low

8.99%

Change from all-time high

-49.79%

Change from all-time low

1,637.14%

Change from open

1.73%

Day's gap

-0.69%

Dollar volume

$64.1M

High price

$36.61

Low price

$35.56

Monthly RSI

43.06

Open price

$35.76

Position in 52-week range

78.1%

Premarket change

-0.36%

Premarket close

$36.01

Premarket price

$35.88

Premarket volume

Previous close

$36.01

Price vs 150-day SMA

-33.17%

Price vs 20-day SMA

1.41%

Price vs 200-day SMA

-30.38%

Price vs 50-day SMA

-21.2%

Relative volume

1.15

RSI

39.54

Sharpe ratio

0.05

Sharpe ratio (3Y)

0.24

Sharpe ratio (5Y)

0.24

Sortino ratio

0.19

Sortino ratio (3Y)

0.52

Sortino ratio (5Y)

0.49

Volume

1.8M

Weekly RSI

32.91

YTD price change

-18.61%

YTD total return

-18.61%

Metric	Value
Float	90.9M
Float percentage	93.86%
Shares change (QoQ)	14.04%
Shares change (YoY)	10.31%
Shares held by insiders	0.17%
Shares held by institutions	100.98%
Shares outstanding	96.8M
Short % of float	6.65%
Short % of shares	6.24%
Short ratio	2.7 days

Metric

Value

Float

90.9M

Float percentage

93.86%

Shares change (QoQ)

14.04%

Shares change (YoY)

10.31%

Shares held by insiders

0.17%

Shares held by institutions

100.98%

Shares outstanding

96.8M

Short % of float

6.65%

Short % of shares

6.24%

Short ratio

2.7 days

Xenon Pharmaceuticals Inc. (XENE)

Price

Financial snapshot

Fair-value bridge

Latest news · XENE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All XENE indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on XENE

Frequently asked questions